Eric A. Adams, CEO of InMed Pharmaceuticals INM, has filed 1 purchase and 0 sales on the open market. The latest trade was on 25/12/19.

EA

EA

Eric A. Adams

President & CEO

Company

InMed Pharmaceuticals INM

First filing

23/03/09

Trades

8 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

25/12/19

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
InMed PharmaceuticalsINM	Open-market buy	24/02/20	24/02/21	41,600 sh	$0.36	$14,976	+1763.5%